Clinical data | |
---|---|
Trade names | Perlutal, Topasel, Unalmes, Yectames, others |
Other names | EEn; E2-EN; EE; E2E; Estradiol enanthate; Estradiol heptanoate; SQ-16150 |
Routes of administration | Intramuscular injection[1][2] |
Drug class | Estrogen; Estrogen ester |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | IM: High |
Protein binding | Estradiol: ~98% (to albumin and SHBG )[3][4] |
Metabolism | Cleavage via esterases in the liver, blood, and tissues[5][6] |
Metabolites | Estradiol, heptanoic acid, and metabolites of estradiol[5][6] |
Elimination half-life | IM: 5.6–7.5 days[7][1][8][9] |
Duration of action | IM (10 mg): ~20–30 days[10][5] |
Excretion | Urine[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.023.272 |
Chemical and physical data | |
Formula | C25H36O3 |
Molar mass | 384.560 g·mol−1 |
3D model (JSmol) | |
| |
|
Estradiol enantate (EEn or E2-EN), also spelled estradiol enanthate and sold under the brand names Perlutal and Topasel among others, is an estrogen medication which is used in hormonal birth control for women.[1][2][11] It is formulated in combination with dihydroxyprogesterone acetophenide (DHPA; algestone acetophenide), a progestin, and is used specifically as a combined injectable contraceptive.[1][2] Estradiol enantate is not available for medical use alone.[12][13][14][15] The medication, in combination with DHPA, is given by injection into muscle once a month.[1][2]
Side effects of estradiol enantate include breast tenderness, breast enlargement, nausea, headache, and fluid retention.[16] Estradiol enantate is an estrogen and hence is an agonist of the estrogen receptor, the biological target of estrogens like estradiol.[6][5] It is an estrogen ester and a long-lasting prodrug of estradiol in the body.[5][6] Because of this, it is considered to be a natural and bioidentical form of estrogen.[5][17]
Estradiol enantate was first described by 1954,[18] and was first studied in combination with DHPA as a combined injectable contraceptive in 1964.[19][20] The combination was introduced for clinical use by the mid-1970s.[21][22][23] Estradiol enantate is not available as a standalone medication (i.e., by itself without DHPA).[15] The combination is available in Latin America and Hong Kong, and was also previously marketed in Spain and Portugal.[15][2][13]
pmid12290848
was invoked but never defined (see the help page).Natural estrogens considered here include: [...] Esters of 17β-estradiol, such as estradiol valerate, estradiol benzoate and estradiol cypionate. Esterification aims at either better absorption after oral administration or a sustained release from the depot after intramuscular administration. During absorption, the esters are cleaved by endogenous esterases and the pharmacologically active 17β-estradiol is released; therefore, the esters are considered as natural estrogens. [...] Wiemeyer et al. (1986) measured elevated estradiol levels up to 31 days after an intramuscular dose of 10mg estradiol enanthate.
pmid3814225
was invoked but never defined (see the help page).pmid8013220
was invoked but never defined (see the help page).pmid8013219
was invoked but never defined (see the help page).Martindale
was invoked but never defined (see the help page).Micromedex
was invoked but never defined (see the help page).Drugs.com
was invoked but never defined (see the help page).IndexNominum2000
was invoked but never defined (see the help page).Ghosh2010
was invoked but never defined (see the help page).Symposium1954
was invoked but never defined (see the help page).pmid14236841
was invoked but never defined (see the help page).pmid14236842
was invoked but never defined (see the help page).BringerHedon1995
was invoked but never defined (see the help page).pmid865726
was invoked but never defined (see the help page).pmid8013216
was invoked but never defined (see the help page).